Accession Number: | 0001415889-19-001558 |
Date: | 2019-12-19 |
Issuer: | AMPIO PHARMACEUTICALS, INC. (AMPE) |
Original Submission Date: |
GILES RICHARD B
C/O AMPIO PHARMACEUTICALS, INC.
373 INVERNESS PARKWAY, SUITE 200
ENGLEWOOD, CO 80112
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
OPTION (RIGHT TO BUY) | 0.465 | 2019-12-19 | deemed execution date | A | 36,000 (a) | 2020-01-14 | 2029-12-19 | common stock 36,000 | $0.47 | 36,000 | direct |
ID | footnote |
---|---|
f1 | 3,000 of the options awarded vest and become exercisable on january 14, 2020. on the 14th of each month thereafter, 3,000 of the options awarded vest until fully vested. |